Immune Therapeutics Inc (OTCQB:IMUN)

0.19
Delayed Data
As of 3:58pm ET
 0.0001 / +0.05%
Today’s Change
0.08
Today|||52-Week Range
1.16
+11.76%
Year-to-Date
No recent news for Immune Therapeutics Inc.

Today’s Trading

Previous close0.19
Today’s open0.18
Day’s range0.17 - 0.19
Volume62,304
Average volume (3 months)194,640
Market cap$19.0M
Dividend yield--
Data as of 3:58pm ET, 03/02/2015

Growth & Valuation

Earnings growth (last year)+72.95%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book0.85

Competitors

No competitors data available.

Financials

Last reporting dateMay 29, 2013
EPS forecast (this quarter)-$0.29
Annual revenue (last year)$0.00
Annual profit (last year)-$106.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Noreen Griffin
President &
Chief Operating Officer
Seth A. Elliott
Corporate headquarters
Orlando, Florida

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account